“Research into the genetic drivers of skin cancer is critical” - MIA Co-Medical Directors Prof Georgina Long AO and Prof Richard Scolyer are co-authors on this study into the link between male pattern baldness and skin cancer.
MIA Co-Medical Directors address the National Press Club of Australia detailing world-first breakthroughs in applying melanoma science to Richard Scolyer’s brain cancer.
A contemporary overview of Cutaneous melanoma, co-authored by MIA, has been published in The Lancet, one of the world's leading medical journals.
The PBAC recommends expanding current PBS listing for pembrolizumab immunotherapy to allow neoadjuvant (before surgery) treatment of resected stage IIIB-D melanoma.
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
Read more about why Prof Richard Scolyer AO received the IAP Distinguished Pathologist Medal and watch his inspiring acceptance speech.
This is the highest award from the American Society of Dermatopathology, and recognises Prof Scolyer's significant contribution to the field of #dermatopathology.
Read more about the five MIA researchers named on the Clarivate list of Highly Cited Researchers 2022.
Read more about the Cancer Institute NSW Awards and the highly cited immunotherapy publication.
Tailoring skin checks based on personal risk, the impact of adjuvant and neo-adjuvant therapies, and the latest in personalised immunotherapy for advanced patients are amongst a plethora of research advances.
